These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5787190)

  • 21. Comparison of the effects of various betaadrenergic blocking agents with known antiarrhythmic drugs on aconitine-arrhythmia produced by the cup method.
    Nakayama K; Oshima T; Kumakura S; Hashimoto K
    Eur J Pharmacol; 1971; 14(1):9-18. PubMed ID: 4396662
    [No Abstract]   [Full Text] [Related]  

  • 22. [Beta adrenergic receptor blocking agents in the treatment of arrhythmia and angina pectoris].
    Fülöp T; Szodoray P
    Orv Hetil; 1969 Oct; 110(41):2387-94. PubMed ID: 5358359
    [No Abstract]   [Full Text] [Related]  

  • 23. Chloral hydrate: the good and the bad.
    Pershad J; Palmisano P; Nichols M
    Pediatr Emerg Care; 1999 Dec; 15(6):432-5. PubMed ID: 10608336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiarrhythmic activity of bunolol, a new beta adrenergic blocking agent.
    Kaplan HR; Robson RD
    J Pharmacol Exp Ther; 1970 Oct; 175(1):168-77. PubMed ID: 4394302
    [No Abstract]   [Full Text] [Related]  

  • 25. Chloral hydrate: Somnos and the thousand sons.
    Mack RB
    N C Med J; 1986 Sep; 47(9):423-4. PubMed ID: 3463875
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiarrhythmic activity of the beta-adrenergic blocking agent 1-isopropylamino-3-(3-tolyloxy)-2-propanol (ICI 45763).
    Somani P
    Am Heart J; 1969 Jan; 77(1):63-71. PubMed ID: 5782851
    [No Abstract]   [Full Text] [Related]  

  • 27. [A new beta blocking agent: LB-46. Clinical use in the treatment of rhythm disorders and coronary insufficiency].
    Dutoit A; Lepoutre B; Leuridan B; Croccel L; Giard P
    J Sci Med Lille; 1972 Feb; 90(2):83-9. PubMed ID: 4403207
    [No Abstract]   [Full Text] [Related]  

  • 28. Direct hyperbilirubinemia associated with chloral hydrate administration in the newborn.
    Lambert GH; Muraskas J; Anderson CL; Myers TF
    Pediatrics; 1990 Aug; 86(2):277-81. PubMed ID: 2371103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of heart arrhythmias with a beta adrenergic blocking agent: Ciba 39,089 Ba].
    Maranhão MF; Lacerda FS; de Cicco LA; Cunha GP
    Arq Bras Cardiol; 1970 Oct; 23(5):327-34. PubMed ID: 4396431
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the mechanism of the antiarrhythmic effect of beta-adrenergic receptor blocking drugs. Experimental research using 2 isomers of butidrin].
    Mastandrea R; Malagnino G; Astorri E; Visoli O
    Boll Soc Ital Cardiol; 1967; 12(5):525-8. PubMed ID: 5606898
    [No Abstract]   [Full Text] [Related]  

  • 31. [The use of the beta-adrenergic blocking agent H56-28 in arrhythmias].
    Cárdenas M; Brenes C; Ruipérez JA; Hermosillo JA
    Arch Inst Cardiol Mex; 1968; 38(5):692-706. PubMed ID: 4178511
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship of isoproterenal and beta-adrenergic blockade to serum potassium.
    Malt SH
    Rev Surg; 1971; 28(6):453. PubMed ID: 4399224
    [No Abstract]   [Full Text] [Related]  

  • 33. The assessment of genotoxic effects in lymphocyte cultures of infants treated with chloral hydrate.
    Ikbal M; Tastekin A; Dogan H; Pirim I; Ors R
    Mutat Res; 2004 Dec; 564(2):159-64. PubMed ID: 15507380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract]   [Full Text] [Related]  

  • 35. [The use of an adrenergic beta-receptor blocking agent in coronary insufficiency and heart rhythm disorders].
    Doshchitsyn VL
    Kardiologiia; 1966; 6(5):65-9. PubMed ID: 6000275
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe esophageal burn following chloral hydrate overdose in an infant.
    Lin YC; Ma JY
    J Formos Med Assoc; 2006 Mar; 105(3):235-7. PubMed ID: 16520840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Butydrine in the treatment of arrhythmia caused by hypertensive drugs in the course of fluothane anesthesia].
    Leonardis G; Splendiani G; Azzarone G
    Minerva Anestesiol; 1969 Oct; 35(10):1017-20. PubMed ID: 4394402
    [No Abstract]   [Full Text] [Related]  

  • 38. Chloral hydrate side effects in young children: causes and management.
    Lipshitz M; Marino BL; Sanders ST
    Heart Lung; 1993; 22(5):408-14. PubMed ID: 8226004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term chloral hydrate administration and cancer in humans.
    Haselkorn T; Whittemore AS; Udaltsova N; Friedman GD
    Drug Saf; 2006; 29(1):67-77. PubMed ID: 16454535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fixed eruption due to chloral hydrate.
    Miller LH; Brownstein MH; Hyman AB
    Arch Dermatol; 1966 Jul; 94(1):60-1. PubMed ID: 5938224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.